Papel de la genética en la etiología de las sinucleinopatías

Ueda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci USA., 90, 11282, 10.1073/pnas.90.23.11282 Jakes, 1994, Identification of two distinct synucleins from human brain, FEBS Lett., 345, 27, 10.1016/0014-5793(94)00395-5 Maroteaux, 1988, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J Neurosci., 8, 2804, 10.1523/JNEUROSCI.08-08-02804.1988 Surguchov, 2008, Molecular and cellular biology of synucleins, Int Rev Cell Mol Biol., 270, 225, 10.1016/S1937-6448(08)01406-8 Kruger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat Genet., 18, 106, 10.1038/ng0298-106 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science., 276, 2045, 10.1126/science.276.5321.2045 Zarranz, 2004, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann Neurol., 55, 164, 10.1002/ana.10795 Beyer, 2006, Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers, Acta Neuropathol., 112, 237, 10.1007/s00401-006-0104-6 Lavedan, 1998, The synuclein family, Genome Res., 8, 871, 10.1101/gr.8.9.871 Ohtake, 2004, Beta-synuclein gene alterations in dementia with Lewy bodies, Neurology., 63, 805, 10.1212/01.WNL.0000139870.14385.3C Braak, 1999, Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry, Neurosci Lett., 265, 67, 10.1016/S0304-3940(99)00208-6 Spillantini, 1998, Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies, Proc Natl Acad Sci USA., 95, 6469, 10.1073/pnas.95.11.6469 Spillantini, 2000, The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, Ann NY Acad Sci., 920, 16, 10.1111/j.1749-6632.2000.tb06900.x Martí, 2003, Clinical overview of the synucleinopathies, Mov Disord., 18, S21, 10.1002/mds.10559 Dawson TM. Parkinson's disease: Genetics and Pathogenesis. 1st ed New York: Informa Healthcare USA Inc; 2007. p. 404. Ji, 1997, Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing, Cancer Res., 57, 759 Chen, 1995, The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis, Genomics., 26, 425, 10.1016/0888-7543(95)80237-G Iwai, 1995, The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system, Neuron., 14, 467, 10.1016/0896-6273(95)90302-X Nakajo, 1994, Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization, Brain Res Mol Brain Res., 27, 81, 10.1016/0169-328X(94)90187-2 George, 1995, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron., 15, 361, 10.1016/0896-6273(95)90040-3 Monti, 2007, Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death, J Neurochem., 103, 518, 10.1111/j.1471-4159.2007.04778.x Xu, 2006, Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells, Biochem Biophys Res Commun., 342, 330, 10.1016/j.bbrc.2006.01.148 Clough, 2009, Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219, J Neurochem., 110, 1479, 10.1111/j.1471-4159.2009.06250.x Clough, 2007, A novel pathway for transcriptional regulation of alphasynuclein, FASEB J., 21, 596, 10.1096/fj.06-7111com Gómez-Santos, 2005, Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage, Brain Res Bull., 65, 87, 10.1016/j.brainresbull.2004.11.008 Kao, 2009, Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors, Biochem Biophys Res Commun., 385, 434, 10.1016/j.bbrc.2009.05.089 Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010:baq020. Beyer, 2008, Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease, Neurogenetics., 9, 163, 10.1007/s10048-008-0124-6 Beyer, 2008, Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases, Neurogenetics., 9, 15, 10.1007/s10048-007-0106-0 Clayton, 1998, The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci., 21, 249, 10.1016/S0166-2236(97)01213-7 Davidson, 1998, Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes, J Biol Chem., 273, 9443, 10.1074/jbc.273.16.9443 Bartels T, Ahlstrom LS, Leftin A, Kamp F, Haass C, Brown MF, et al. The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding. Biophys J.;99:2116-24. Han, 1995, The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?, Chem Biol., 2, 163, 10.1016/1074-5521(95)90071-3 Jao, 2004, Structure of membrane-bound alphasynuclein studied by site-directed spin labeling, Proc Natl Acad Sci USA., 101, 8331, 10.1073/pnas.0400553101 Norris, 2004, Alpha-synuclein: normal function and role in neurodegenerative diseases, Curr Top Dev Biol., 60, 17, 10.1016/S0070-2153(04)60002-0 Weinreb, 1996, NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry., 35, 13709, 10.1021/bi961799n Giasson, 1999, Mutant and wild type human alphasynucleins assemble into elongated filaments with distinct morphologies in vitro, J Biol Chem., 274, 7619, 10.1074/jbc.274.12.7619 Wakabayashi, 2000, NACP/alphasynuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains, Acta Neuropathol., 99, 14, 10.1007/PL00007400 Beyer, 2007, Protein aggregation mechanisms in synucleinopathies: commonalities and differences, J Neuropathol Exp Neurol., 66, 965, 10.1097/nen.0b013e3181587d64 Adamczyk, 2010, Alpha-synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxidedependent activation of caspase-3, FEBS Lett., 584, 3504, 10.1016/j.febslet.2010.07.019 Campion, 1995, The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease, Genomics., 26, 254, 10.1016/0888-7543(95)80208-4 Ueda, 1994, Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid, Biochem Biophys Res Commun., 205, 1366, 10.1006/bbrc.1994.2816 Beyer, 2004, Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies, Neuropathol Appl Neurobiol., 30, 601, 10.1111/j.1365-2990.2004.00572.x Yu, 2010, Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats, PLoS One., 5, e9956, 10.1371/journal.pone.0009956 Hunter, 1995, Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling, Cell., 80, 225, 10.1016/0092-8674(95)90405-0 Ellis, 2001, Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases, J Biol Chem., 276, 3879, 10.1074/jbc.M010316200 Nakamura, 2002, Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases, FEBS Lett., 521, 190, 10.1016/S0014-5793(02)02861-2 Okochi, 2000, Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein, J Biol Chem., 275, 390, 10.1074/jbc.275.1.390 Fujiwara, 2002, Alpha-synuclein is phosphorylated in synucleinopathy lesions, Nat Cell Biol., 4, 160, 10.1038/ncb748 Smith, 2005, Alphasynuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells, J Neurosci., 25, 5544, 10.1523/JNEUROSCI.0482-05.2005 Anderson, 2006, Phosphorylation of Ser-129 is the dominant pathological modification of alphasynuclein in familial and sporadic Lewy body disease, J Biol Chem., 281, 29739, 10.1074/jbc.M600933200 Saito, 2003, Accumulation of phosphorylated alpha-synuclein in aging human brain, J Neuropathol Exp Neurol., 62, 644, 10.1093/jnen/62.6.644 Lou, 2010, Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo, J Biol Chem., 285, 17648, 10.1074/jbc.M110.100867 Chen, 2009, Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation, J Clin Invest., 119, 3257 Paleologou, 2010, Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions, J Neurosci., 30, 3184, 10.1523/JNEUROSCI.5922-09.2010 Paleologou, 2008, Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein, J Biol Chem., 283, 16895, 10.1074/jbc.M800747200 Al-Wandi, 2010, Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice, Neurobiol Aging., 31, 796, 10.1016/j.neurobiolaging.2008.11.001 Greten-Harrison, 2010, {alpha}{beta}{gamma}-synuclein triple knockout mice reveal age-dependent neuronal dysfunction, Proc Natl Acad Sci USA., 107, 19573, 10.1073/pnas.1005005107 Jensen, 1998, Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation, J Biol Chem., 273, 26292, 10.1074/jbc.273.41.26292 McLean, 2000, Membrane association and protein conformation of alpha-synuclein in intact neurons, Effect of Parkinson's diseaselinked mutations. J Biol Chem., 275, 8812 Lotharius, 2002, Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease, Hum Mol Genet., 11, 2395, 10.1093/hmg/11.20.2395 Ben Gedalya, 2009, Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling, Traffic., 10, 218, 10.1111/j.1600-0854.2008.00853.x Jenco, 1998, Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins, Biochemistry., 37, 4901, 10.1021/bi972776r Ahn, 2002, Alpha-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells, J Biol Chem., 277, 12334, 10.1074/jbc.M110414200 Rappley, 2009, Evidence that alpha-synuclein does not inhibit phospholipase D, Biochemistry., 48, 1077, 10.1021/bi801871h Bellani, 2010, The regulation of synaptic function by alpha-synuclein, Commun Integr Biol., 3, 106, 10.4161/cib.3.2.10964 Abeliovich, 2000, Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron., 25, 239, 10.1016/S0896-6273(00)80886-7 Ferrer, 2001, Alpha-synucleinopathies. Neurologia, 16, 163 Ostrerova, 1999, Alpha-synuclein shares physical and functional homology with 14-3-3 proteins, J Neurosci., 19, 5782, 10.1523/JNEUROSCI.19-14-05782.1999 Pérez, 2002, A role for alpha-synuclein in the regulation of dopamine biosynthesis, J Neurosci., 22, 3090, 10.1523/JNEUROSCI.22-08-03090.2002 Zhang, 1997, Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49, J Biol Chem., 272, 13717, 10.1074/jbc.272.21.13717 Alerte, 2008, Alphasynuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice, Neurosci Lett., 435, 24, 10.1016/j.neulet.2008.02.014 Ichimura, 1988, Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinasedependent activator of tyrosine and tryptophan hydroxylases, Proc Natl Acad Sci USA., 85, 7084, 10.1073/pnas.85.19.7084 Burke, 2004, Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases, Neurotoxicology., 25, 101, 10.1016/S0161-813X(03)00090-1 Eisenhofer, 2004, Catecholamine metabolism: a contemporary view with implications for physiology and medicine, Pharmacol Rev., 56, 331, 10.1124/pr.56.3.1 Bisaglia, 2007, Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein, J Biol Chem., 282, 15597, 10.1074/jbc.M610893200 Conway, 2001, Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct, Science., 294, 1346, 10.1126/science.1063522 Martínez-Vicente, 2008, Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy, J Clin Invest., 118, 777 Bisaglia, 2010, Alphasynuclein overexpression increases dopamine toxicity in BE2-M17 cells, BMC Neurosci., 11, 41, 10.1186/1471-2202-11-41 Damier, 1999, The substantia nigra of the human brain, II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain., 122, 1437 Arita, 1985, In vitro dopamine biosynthesis in the median eminence of rat hypothalamic slices: involvement of voltage-dependent Ca2+ channels, Brain Res., 347, 299, 10.1016/0006-8993(85)90190-8 Mosharov, 2009, Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons, Neuron., 62, 218, 10.1016/j.neuron.2009.01.033 Chan, 2007, ‘Rejuvenation’ protects neurons in mouse models of Parkinson's disease, Nature., 447, 1081, 10.1038/nature05865 Touchman, 2001, Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element, Genome Res., 11, 78, 10.1101/gr.165801 Shibasaki, 1995, High-resolution mapping of SNCA encoding alpha-synuclein, the non-A beta component of Alzheimer's disease amyloid precursor, to human chromosome 4q21.3 → q22 by fluorescence in situ hybridization, Cytogenet Cell Genet., 71, 54, 10.1159/000134061 Tanaka, 2009, HapMap project, Nippon Rinsho., 67, 1068 Jenuth, 2000, The NCBI. Publicly available tools and resources on the Web. Methods Mol Biol, 132, 301 Beyer, 2007, A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging, J Neurosci Res., 85, 1538, 10.1002/jnr.21270 Yu, 2010, SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population, Brain Res., 1346, 262, 10.1016/j.brainres.2010.05.069 Al-Chalabi, 2009, Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy, PLoS One., 4, e7114, 10.1371/journal.pone.0007114 Tan, 2004, Alpha-synuclein haplotypes implicated in risk of Parkinson's disease, Neurology., 62, 128, 10.1212/01.WNL.0000101721.25345.DC Maraganore, 2006, Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease, JAMA., 296, 661, 10.1001/jama.296.6.661 Myhre, 2008, Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population, Acta Neurol Scand., 118, 320, 10.1111/j.1600-0404.2008.01019.x Spadafora, 2003, NACPREP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy, Neurosci Lett., 351, 75, 10.1016/S0304-3940(03)00859-0 Ross, 2007, Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease, Mech Ageing Dev., 128, 378, 10.1016/j.mad.2007.04.002 Linnertz, 2009, Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues, PLoS One., 4, e7480, 10.1371/journal.pone.0007480 Mata, 2010, SNCA variant associated with Parkinson disease and plasma alpha-synuclein level, Arch Neurol., 67, 1350, 10.1001/archneurol.2010.279 Chiba-Falek, 2003, Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene, Hum Genet., 113, 426, 10.1007/s00439-003-1002-9 Sotiriou, 2009, A single nucleotide polymorphism in the 3’UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease, Neurosci Lett., 461, 196, 10.1016/j.neulet.2009.06.034 Hu, 2010, Lack of replication of a previously reported association between polymorphism in the 3’UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects, Neurosci Lett., 479, 31, 10.1016/j.neulet.2010.05.022 Winkler, 2007, Alpha-synuclein and Parkinson disease susceptibility, Neurology., 69, 1745, 10.1212/01.wnl.0000275524.15125.f4 Rajput, 2009, Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population, Mov Disord., 24, 2411, 10.1002/mds.22795 Junn, 2009, Repression of alphasynuclein expression and toxicity by microRNA-7, Proc Natl Acad Sci USA., 106, 13052, 10.1073/pnas.0906277106 Otto, 2002, The evolution of gene duplicates, Adv Genet., 46, 451, 10.1016/S0065-2660(02)46017-8 Zhang, 2001, Gene duplication and evolution, Science., 293, 1551, 10.1126/science.293.5535.1551a Zhang, 2004, How much expression divergence after yeast gene duplication could be explained by regulatory motif evolution?, Trends Genet., 20, 403, 10.1016/j.tig.2004.07.006 Chartier-Harlin, 2004, Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet., 364, 1167, 10.1016/S0140-6736(04)17103-1 Ibánez, 2004, Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease, Lancet., 364, 1169, 10.1016/S0140-6736(04)17104-3 Miller, 2004, Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication, Neurology., 62, 1835, 10.1212/01.WNL.0000127517.33208.F4 Singleton, 2003, Alphasynuclein locus triplication causes Parkinson's disease, Science., 302, 841, 10.1126/science.1090278 Keri, 2010, [alpha]-Synuclein gene duplication impairs reward learning, Proc Natl Acad Sci USA., 107, 15992, 10.1073/pnas.1006068107 Nishioka, 2006, Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease, Ann Neurol., 59, 298, 10.1002/ana.20753 Winslow, 2010, Alpha-synuclein impairs macroautophagy: implications for Parkinson's disease, J Cell Biol., 190, 1023, 10.1083/jcb.201003122 Ikeuchi, 2008, Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia, Arch Neurol., 65, 514, 10.1001/archneur.65.4.514 Ahn, 2008, alpha-Synuclein gene duplication is present in sporadic Parkinson disease, Neurology., 70, 43, 10.1212/01.wnl.0000271080.53272.c7 Brueggemann, 2008, Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease [author reply], Neurology., 71, 1294, 10.1212/01.wnl.0000338439.00992.c7 Troiano, 2008, Re: Alphasynuclein gene duplication is present in sporadic Parkinson disease [author reply], Neurology., 71, 1295, 10.1212/01.wnl.0000338435.78120.0f Jensen, 2003, Alpha-synuclein protects naive but not dbcAMPtreated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity, J Neurochem., 86, 196, 10.1046/j.1471-4159.2003.01835.x Alves da Costa, 2002, Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells, Abolishment by 6-hydroxydopamine and implication for Parkinson's disease. J Biol Chem., 277, 50980 Da Costa, 2000, Wild-type but not Parkinson's disease-related ala-53 → Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli, J Biol Chem., 275, 24065, 10.1074/jbc.M002413200 Perrin, 2000, Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids, Structural analysis using site-directed mutagenesis. J Biol Chem., 275, 34393 Sousa, 2009, [alpha]- Synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics, Mol Biol Cell., 20, 3725, 10.1091/mbc.E08-03-0302 Saha, 2004, Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons, J Cell Sci., 117, 1017, 10.1242/jcs.00967 Greenbaum, 2005, The E46K mutation in alpha-synuclein increases amyloid fibril formation, J Biol Chem., 280, 7800, 10.1074/jbc.M411638200 Rospigliosi, 2009, E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein, J Mol Biol., 388, 1022, 10.1016/j.jmb.2009.03.065 Anderson, 2010, Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation, Proc Natl Acad Sci USA., 107, 18850, 10.1073/pnas.1012336107 Harada, 2009, The effect of amino acid substitution in the imperfect repeat sequences of alpha-synuclein on fibrillation, Biochim Biophys Acta., 1792, 998, 10.1016/j.bbadis.2009.06.010 Choi, 2004, Mutation E46K increases phospholipid binding and assembly into filaments of human alphasynuclein, FEBS Lett., 576, 363, 10.1016/j.febslet.2004.09.038 Conway, 1998, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat Med., 4, 1318, 10.1038/3311 Narhi, 1999, Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation, J Biol Chem., 274, 9843, 10.1074/jbc.274.14.9843 Cuervo, 2004, Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy, Science., 305, 1292, 10.1126/science.1101738 Kahle, 2002, Structure/function of alphasynuclein in health and disease: rational development of animal models for Parkinson's and related diseases, J Neurochem., 82, 449, 10.1046/j.1471-4159.2002.01020.x Sayers, 2010, Database resources of the National Center for Biotechnology Information, Nucleic Acids Res., 38, D5, 10.1093/nar/gkp967 Duda, 2000, Neuropathology of synuclein aggregates, J Neurosci Res., 61, 121, 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4 Uversky, 2002, Biophysica properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins, J Biol Chem., 277, 11970, 10.1074/jbc.M109541200 Snyder, 2005, Betasynuclein reduces proteasomal inhibition by alpha-synuclein but not gammasynuclein, J Biol Chem., 280, 7562, 10.1074/jbc.M412887200 Fan, 2006, Betasynuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression, Hum Mol Genet., 15, 3002, 10.1093/hmg/ddl242 Israeli, 2009, Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein, J Neurochem., 108, 465, 10.1111/j.1471-4159.2008.05776.x Auluck, 2002, Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease, Science., 295, 865, 10.1126/science.1067389 Hashimoto, 2004, Betasynuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease, J Biol Chem., 279, 23622, 10.1074/jbc.M313784200 Kim, 2000, Structural changes in alpha-synuclein affect its chaperone-like activity in vitro, Protein Sci., 9, 2489, 10.1110/ps.9.12.2489 Lee, 2004, Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein, FEBS Lett., 576, 256, 10.1016/j.febslet.2004.08.075 Rekas, 2004, Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity, J Mol Biol., 340, 1167, 10.1016/j.jmb.2004.05.054 Pronin, 2000, Synucleins are a novel class of substrates for G protein-coupled receptor kinases, J Biol Chem., 275, 26515, 10.1074/jbc.M003542200 Lavedan, 1998, Genomic organization and expression of the human beta-synuclein gene (SNCB), Genomics., 54, 173, 10.1006/geno.1998.5556 Brighina, 2007, Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study, Neurosci Lett., 420, 229, 10.1016/j.neulet.2007.05.021 Surgucheva, 2006, Gamma-synuclein has a dynamic intracellular localization, Cell Motil Cytoskeleton., 63, 447, 10.1002/cm.20135 Surgucheva, 2002, Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve, J Neurosci Res., 68, 97, 10.1002/jnr.10198 Surguchov, 2001, Synucleins in ocular tissues, J Neurosci Res., 65, 68, 10.1002/jnr.1129 Buchman, 1998, Persyn, a member of the synuclein family, influences neurofilament network integrity, Nat Neurosci., 1, 101, 10.1038/349 Buchman, 1998, Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system, J Neurosci., 18, 9335, 10.1523/JNEUROSCI.18-22-09335.1998 Gu, 2008, BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer, Oncology., 74, 61, 10.1159/000139125 Lu, 2006, Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells, Sci China C Life Sci., 49, 403, 10.1007/s11427-006-2006-1 Lu, 2002, Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells, J Biol Chem., 277, 31364, 10.1074/jbc.M201060200 Ninkina, 1998, Organization, expression and polymorphism of the human persyn gene, Hum Mol Genet., 7, 1417, 10.1093/hmg/7.9.1417 Lavedan, 1998, Contig map of the Parkinson's disease region on 4q21-q23, DNA Res, 5, 19, 10.1093/dnares/5.1.19 Su, 2003, Study on gamma-synuclein gene in patients with idiopathic Parkinson's disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi., 20, 444 Kruger, 2001, Evaluation of the gamma-synuclein gene in German Parkinson's disease patients, Neurosci Lett., 310, 191, 10.1016/S0304-3940(01)02127-9 Flowers, 1999, Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease, Neurosci Lett., 274, 21, 10.1016/S0304-3940(99)00673-4 Nishioka, 2010, Association of alpha-, beta-, and gamma-synuclein with diffuse lewy body disease, Arch Neurol., 67, 970, 10.1001/archneurol.2010.177